EN
登录

2023年美国透皮贴剂市场报告:2029年剂量、价格和临床试验见解-关注阿片类药物、心血管疾病、神经系统疾病和激素治疗

United States Transdermal Patch Market Report 2023: Dosage, Price & Clinical Trials Insights to 2029 - Focus on Opioid, Cardiovascular Diseases, Neurological Disorders, and Hormonal Therapy

businesswire 等信源发布 2023-11-23 22:42

可切换为仅中文


DUBLIN--(BUSINESS WIRE)--The 'US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029' report has been added to ResearchAndMarkets.com's offering.

都柏林-(商业线)--“美国透皮贴剂市场,剂量,价格和临床试验洞察2029”报告已添加到ResearchAndMarkets.com的产品中。

The US transdermal patch market offers a plethora of opportunities encouraged by patient convenience, therapeutic versatility and the potential to address healthcare challenges such as pain management and vaccine administration.

美国透皮贴剂市场提供了由患者便利性,治疗多功能性和解决诸如疼痛管理和疫苗管理等医疗保健挑战的潜力所鼓励的大量机会。

As technology continues to advance, and as patient preferences shift towards non-invasive and user-friendly drug delivery methods, the market for transdermal patches is expected to experience significant growth. Pharmaceutical companies and researchers are continuously exploring and investing in this field, which will continue in the coming years as well..

随着技术的不断进步,以及患者偏好转向非侵入性和用户友好的药物输送方法,透皮贴剂市场预计将经历显着增长。制药公司和研究人员正在不断探索和投资这一领域,这将在未来几年继续下去。。

With the rapid approvals of transdermal patches lately, the FDA has also marked itself as an important player in the US market of transdermal patches. The FDA provides a detailed communication on the requirements of an ideal transdermal patch, and patches that meet these are allowed entry in the regional market.

随着最近透皮贴剂的快速批准,FDA也将自己标记为美国透皮贴剂市场的重要参与者。FDA提供有关理想透皮贴剂要求的详细信息,并且允许符合这些要求的贴剂进入区域市场。

In September 2023, the FDA approved Zydus Lifesciences' transdermal patch to prevent pregnancy. The patch is a generic version of a marketed hormonal patch and contains norelgestromin and ethinyl estradiol as its active ingredients..

2023年9月,FDA批准Zydus Lifesciences的透皮贴剂预防怀孕。该贴剂是市售激素贴剂的通用版本,含有norelgestromin和乙炔雌二醇作为其活性成分。。

In addition, as patent protection of some commonly used patches are coming to end, generic competition is expected to drive innovation in the market.

此外,随着一些常用补丁的专利保护即将结束,预计仿制药竞争将推动市场创新。

Competitive Landscape

竞争格局

Transdermal patches are an innovative means of delivering medications to the body and keeping medicine doses at the ideal levels required to treat an illness. The majority of transdermal patches on the market are reformulated versions of existing medications that are delivered orally or subcutaneously, and were produced after the patents on these drugs expired.

透皮贴剂是将药物输送到身体并将药物剂量保持在治疗疾病所需的理想水平的创新手段。市场上的大多数透皮贴剂是口服或皮下递送的现有药物的重新配制版本,并且是在这些药物的专利过期后生产的。

. In the US, the landscape of transdermal patch development is highly active, with contributions from both pharmaceutical corporations and researchers, who are now looking for creative ways to improve the features of these patches compared to conventional transdermal.

在美国,透皮贴剂开发的前景非常活跃,制药公司和研究人员都做出了贡献,与传统的透皮贴剂相比,他们现在正在寻找创新的方法来改善这些贴剂的特性。

It is anticipated that over 100 clinical studies are being done globally to evaluate investigational transdermal patches, with approximately 50 of them taking place in the US. Neurological illnesses are currently dominating clinical trials in terms of indications. The most prospects are being developed for Parkinson's and Alzheimer's diseases..

预计全球将进行100多项临床研究以评估研究性透皮贴剂,其中约50项在美国进行。神经系统疾病目前在适应症方面占主导地位的临床试验。帕金森病和阿尔茨海默病的前景最为广阔。。

The number of people in the US suffering from neurological diseases has grown in recent years, as contributing environmental variables have increased in this age of modernization. With increased awareness of transdermal patches and their patient-friendliness, they are quickly becoming one of the most popular therapeutic interventions for these disorders..

近年来,美国患有神经系统疾病的人数有所增加,因为在这个现代化时代,环境变量的贡献也在增加。随着对透皮贴剂的认识和对患者的友好性的提高,它们正迅速成为这些疾病最流行的治疗干预措施之一。。

Transdermal patches are attracting interest in the US market for a variety of indications, particularly those that require long term treatment, such as cardiovascular disorders and chronic pain. The US is emerging as a hotspot for transdermal patch development, with many big and small companies executing clinical trials for transdermal patches created for various indications in the region..

透皮贴剂吸引了美国市场对各种适应症的兴趣,特别是那些需要长期治疗的适应症,如心血管疾病和慢性疼痛。美国正在成为透皮贴剂开发的热点,许多大小公司正在为该地区各种适应症创建的透皮贴剂进行临床试验。。

Transdermal patches for pain relief are also an important field of study and development in the US. Aside from pain produced by joint difficulties, muscle strains, and nerve damage, among other things, researchers are focusing on pain caused by various health diseases such as cancer or its treatment, as well as pain experienced after specific surgeries..

用于缓解疼痛的透皮贴剂也是美国研究和开发的重要领域。除了由关节困难,肌肉紧张和神经损伤等引起的疼痛之外,研究人员还关注由各种健康疾病引起的疼痛,例如癌症或其治疗,以及特定手术后经历的疼痛。。

Transdermal patches release the drug at a steady rate over several hours, giving pain relief and serving as the most convenient alternative for pain reduction. Furthermore, unlike oral pain relievers, which can produce unpleasant events such as gastritis, transdermal patches have no substantial side effects..

透皮贴剂在数小时内以稳定的速度释放药物,缓解疼痛并作为减轻疼痛的最方便的替代方案。此外,与口服止痛药不同,口服止痛药会产生令人不快的事件,如胃炎,透皮贴剂没有明显的副作用。。

Several medical universities and health centers in the US are also involved in the research and development of transdermal patches at present, and several of their products are now undergoing late phase clinical trials in the region. For instance, the Washington University School of Medicine is conducting a phase III trial for its buprenorphine transdermal matrix patch in pregnant patients with opioid use disorder..

目前,美国的几所医科大学和保健中心也参与透皮贴剂的研究和开发,其中一些产品目前正在该地区进行后期临床试验。例如,华盛顿大学医学院正在对怀孕的阿片类药物使用障碍患者进行丁丙诺啡透皮基质贴剂的III期临床试验。。

The aim of the trial is to see if the patch can induce opioid withdrawal in these subjects, which will determine the feasibly of the protocol of using patches as a bridge towards using sublingual buprenorphine films. Some others are the University of California, Davis and the Brown University that are conducting trials for oxybutynin and nicotine-based transdermal patches, respectively..

该试验的目的是观察贴剂是否可以在这些受试者中诱导阿片类药物戒断,这将决定使用贴剂作为使用舌下丁丙诺啡膜的桥梁的方案的可行性。其他一些是加州大学戴维斯分校和布朗大学,分别正在进行奥昔布宁和尼古丁透皮贴剂的试验。。

US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029 Report Highlights:

美国透皮贴剂市场,剂量,价格和临床试验Insight 2029报告重点:

US Transdermal Patch Market Opportunity: > US$ 5 Billion By 2029

美国透皮贴剂市场机会:到2029年>50亿美元

Commercially available Patches In US Market: > 25 Patches

美国市场上的商用补丁:>25个补丁

Clinical Insight On All approved transdermal Patches In US Market

美国市场上所有批准的透皮贴剂的临床见解

Ongoing Clinical Trials Of Transdermal Patches in US: > 40 Patches

美国正在进行的透皮贴剂临床试验:>40个贴剂

US Transdermal Patch Clinical Trials Insight By Company, Indication & Phase

美国透皮贴剂临床试验洞察公司,适应症和阶段

Dosage & Price Insight Of Approved Patches By Indications

通过适应症批准的贴剂的剂量和价格洞察

Key Topics Covered:

涵盖的主要主题:

1. Research Methodology

1.研究方法

2. US Transdermal Patch Market Outlook

2.美国透皮贴剂市场前景

2.1 Approved Transdermal Patches Insight

2.1批准的透皮贴剂见解

2.2 Current Market Scenario

2.2目前的市场情景

2.3 Favorable Market Growth Inhibitors

2.3有利的市场增长抑制剂

2.4 Clinical & Commercialization Challenges

2.4临床和商业化挑战

2.5 Future Marketing Opportunities

2.5未来的营销机会

3. Branded vs Generic Transdermal Patches Comparison

3.品牌与通用透皮贴剂比较

4. Transdermal Patch Clinical & Market Trends By Indication

4.通过适应症透皮贴剂临床和市场趋势

4.1 Brain, Neurological & Psychotic Disorders

4.1脑,神经和精神障碍

4.2 Hormone Modulators

4.2激素调节剂

4.2.1 Hormone Replacement Therapies (HRT)

4.2.1激素替代疗法(HRT)

4.2.2 Contraception

4.2.2避孕

4.3 Diabetes

4.3糖尿病

4.4 Vaccine

4.4疫苗

4.5 Substance Use Disorders

4.5物质使用障碍

4.6 Cardiovascular Diseases

4.6心血管疾病

5. US Transdermal Patch Clinical Pipeline Overview

5.美国透皮贴剂临床管道概述

5.1 By Company

5.1公司

5.2 By Drug Class

5.2按毒品类别

5.3 By Indication

5.3通过指示

5.4 By Phase

5.4分相

5.5 By Priority Status

5.5按优先地位

6. Cardiovascular Diseases Transdermal Patch - US Market Availability, Dosage & Price Analysis

6.心血管疾病透皮贴剂-美国市场可用性,剂量和价格分析

6.1 Clonidine Transdermal Patch

6.1可乐定透皮贴剂

6.2 Nitroglycerin Transdermal Patch

6.2硝酸甘油透皮贴剂

7. Opioid Drug Containing Transdermal Patches - US Market Availability, Dosage & Price Analysis

7.含阿片类药物的透皮贴剂-美国市场可用性,剂量和价格分析

7.1 Fentanyl Transdermal Patch

7.1芬太尼透皮贴剂

7.2 Buprenorphine Transdermal Patch

7.2丁丙诺啡透皮贴剂

8. Neurological Disorders Transdermal Patch - US Market Availability, Dosage & Price Analysis

8.神经系统疾病透皮贴剂-美国市场可用性,剂量和价格分析

8.1 Selegiline Transdermal Patch

8.1司来吉兰透皮贴剂

8.2 Rivastigmine Transdermal Patch

8.2利凡斯的明透皮贴剂

8.3 Methylphenidate Transdermal Patch

8.3哌醋甲酯透皮贴剂

8.4 Asenapine Transdermal Patch

8.4 Asenapine透皮贴剂

8.5 Rotigotine Transdermal Patch (Neupro) sales

8.5罗替戈汀透皮贴剂(Neupro)销售

8.6 Donepezil Transdermal Patch

8.6多奈哌齐透皮贴剂

8.7 Dextroamphetamine Transdermal Patch

8.7右旋安非他明透皮贴剂

9. Hormonal Therapy Transdermal Patch - US Market Availability, Dosage & Price Analysis

9.激素疗法透皮贴剂-美国市场可用性,剂量和价格分析

9.1 Estradiol Transdermal Patch

9.1雌二醇透皮贴剂

9.2 Testosterone Transdermal Patch (Androderm)

9.2睾酮透皮贴剂(Androderm)

10. Transdermal Patches for Other Conditions - US Market Availability, Dosage & Price Analysis

10.其他条件下的透皮贴剂-美国市场可用性,剂量和价格分析

10.1 Nicotine Transdermal Patch

10.1尼古丁透皮贴剂

10.2 Oxybutynin Transdermal Patch

10.2氧丁炔素透皮贴剂

10.3 Granisetron Transdermal Patch (Sancuso)

10.3 Granisetron透皮贴片(Sancuso)

11. US Transdermal Patch Clinical Trials Insight By Company, Indication & Phase

11.美国透皮贴剂临床试验公司的洞察力,适应症和阶段

11.1 Research

11.1研究

11.2 Preclinical

11.2临床前

11.3 Phase-I

11.3第一阶段

11.4 Phase-II

11.4第二阶段

11.5 Phase-III

11.5第三阶段

11.6 Preregistration

11.6预注册

11.7 Registered

11.7注册

12. US Commercially Available Transdermal Patches Clinical Insight by Indication

12.美国市售透皮贴剂临床适应症

13. Competitive Landscape

13.竞争格局

13.1 AbbVie

13.1 AbbVie

13.2 AFYX Therapeutics

13.2 AFYX疗法

13.3 Agile Therapeutics

13.3敏捷疗法

13.4 Bayer HealthCare Pharmaceuticals

13.4拜耳医药保健

13.5 Corsair Pharma

13.5 Corsair制药

13.6 DBV Technologies

13.6 DBV技术

13.7 Hisamitsu Pharmaceutical

13.7 Hisamitsu制药

13.8 IBSA

13.8磅/平方英寸

13.9 Privo Technologies

13.9 Privo技术

13.10 Psilera

13.10 Psilera

13.11 Starton Therapeutics

13.11 Starton Therapeutics

13.12 Teikoku Pharma USA

13.12 Teikoku Pharma USA

13.13 Teikoku Seiyaku

13.13 Seiyaku

13.14 UCB

13.14 UCB

13.15 Vaxess Technologiess

13.15 Vaxess Technologies

13.16 Verndari

13.16保护器

For more information about this report visit https://www.researchandmarkets.com/r/5l2nd1

有关此报告的更多信息,请访问https://www.researchandmarkets.com/r/5l2nd1

About ResearchAndMarkets.com

关于ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com是国际市场研究报告和市场数据的全球领先来源。我们为您提供有关国际和区域市场,关键行业,顶级公司,新产品和最新趋势的最新数据。